Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Regulatory News (HCM)

Share Price Information for Hutchmed (HCM)

Share Price is delayed by 15 minutes
Get Live Data
161.50    -11.00 (-6.38%)
Bid:
158.50
Ask:
162.50
Spread: 4.00 (2.524%)
Market Cap: £1.39b
HCM Live PriceLast checked at - London Stock Exchange

Intraday Hutchmed Share Chart

Blocklisting Six Monthly Return

29 Jun 2015 07:00

RNS Number : 4650R
Hutchison China Meditech Limited
29 June 2015
 

 

 

 

Blocklisting Six Monthly Return

 

 

London: Monday, 29 June 2015: Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) announces the following blocklisting six monthly return:

 

1.

Name of applicant:

 

Hutchison China MediTech Limited

2.

Name of scheme:

 

Hutchison China MediTech Limited Share Option Scheme

 

3.

Period of return:

 

From 29 December 2014 to 28 June 2015

4.

Balance under scheme from previous return:

 

696,051 ordinary shares of US$1 each

 

5.

The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return:

 

Nil

6.

Number of securities issued/allotted under scheme during period:

223,288 ordinary shares of US$1 each

7.

Balance under scheme not yet issued/allotted at end of the period:

 

472,763 ordinary shares of US$1 each

8.

Number and class of securities originally listed and the date of admission:

 

2,560,606 ordinary shares of US$1 each admitted on 26 June 2007

9.

Total number of securities in issue at the end of the period:

53,299,964 ordinary shares of US$1 each

Name of contact:

 

Christian Hogg

Address of contact:

 

21/F., Hutchison House, 10 Harcourt Road, Hong Kong

 

Telephone number of contact:

 

+852 2121 8200

 

 

Ends

 

 

Enquiries

 

Chi-Med

Christian Hogg, CEO

Telephone: +852 2121 8200

 

Panmure Gordon (UK) Limited

Telephone: +44 20 7886 2500

Richard Gray

Andrew Potts

 

 

Citigate Dewe Rogerson

Anthony Carlisle

David Dible

Telephone: +44 20 7638 9571

Mobile: +44 7973 611 888

Mobile: +44 7967 566 919

 

About Chi-Med

 

Chi-Med is a China-based healthcare group focused on researching, developing, manufacturing and selling pharmaceuticals and health-related consumer products. Its Drug R&D Division focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases. Its China Healthcare Division manufactures, markets and distributes prescription and over-the-counter pharmaceuticals in China. Its emerging Consumer Products Division focuses on organic and natural consumer products in Asia.

 

Chi-Med is majority owned by the multinational conglomerate CK Hutchison Holdings Limited (SEHK:1). For more information, please visit: www.chi-med.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRUKSVRVWANURR
Date   Source Headline
13th Jul 20097:00 amRNSHMPL-004 Delivers Encouraging Phase II Results
8th Jul 20097:00 amRNSNotice of Results
30th Jun 20097:00 amRNSBlocklisting Six Monthly Return
8th May 20092:43 pmRNSResult of AGM
9th Apr 20091:19 pmRNSDirector/PDMR Shareholding
6th Apr 20097:00 amRNS2008 Annual Report and Notice of AGM
20th Mar 200911:40 amRNSNotice of AGM
20th Mar 200911:38 amRNSHolding(s) in Company
20th Mar 20097:00 amRNSHolding(s) in Company
16th Mar 20097:00 amRNSFinal Results
2nd Mar 20098:44 amRNSHolding(s) in Company
27th Feb 200911:11 amRNSNotice of Results
17th Feb 20097:00 amRNSCompletion of US Phase II Patient Enrolment
22nd Jan 20091:00 pmRNSHolding(s) in Company
22nd Jan 20091:00 pmRNSHolding(s) in Company
21st Jan 200910:43 amRNSHolding(s) in Company
19th Jan 20098:24 amRNSDirector/PDMR Shareholding
8th Jan 20097:00 amRNSClinical Update on HMPL-002
30th Dec 20087:00 amRNSBlocklisting Six Monthly Return
23rd Dec 200810:30 amRNSDrug Discovery and Development Partnership
15th Dec 20089:33 amRNSDirector/PDMR Shareholding
21st Nov 20087:00 amRNSChi-Med Expands Partnership With Lilly
30th Oct 20087:00 amRNSHutchison MediPharma Wins ACG Award
8th Oct 20087:00 amRNSBoard Change
6th Aug 20087:00 amRNSHutchison MediPharma Employee
6th Aug 20087:00 amRNSInterim Results
18th Jul 20087:00 amRNSNotice of Results
30th Jun 20088:48 amRNSBlocklisting Six Monthly Retu
10th Jun 20089:11 amRNSDirector/PDMR Shareholding
2nd Jun 20087:00 amRNSDirectorate Change
23rd May 20087:00 amRNSChi-Med increases stake in Hu
19th May 20087:00 amRNSSen French Launch
22nd Apr 20081:56 pmRNSHolding(s) in Company
9th Apr 20087:00 amRNSAnnual Report and Accounts
31st Mar 200810:31 amRNSHolding(s) in Company
19th Mar 20087:13 amRNSPreliminary Results
29th Feb 20087:00 amRNSClinical Update
28th Feb 20087:02 amRNSAddress Change Cayman Islands
28th Feb 20087:00 amRNSNotice of Results
21st Jan 20087:00 amRNSChina Healthcare division
27th Dec 20077:00 amRNSBlock Admission Return
22nd Nov 20077:03 amRNSResearch Update
20th Aug 20077:00 amRNSAgreement with Eli Lilly
9th Aug 20077:01 amRNSInterim Results
18th Jul 20077:00 amRNSNotice of Results
2nd Jul 20077:01 amRNSResearch Update
22nd Jun 20077:00 amRNSBlock Admission
18th Jun 20077:00 amRNSR&D Facility Purchase
23rd May 20077:00 amRNSResearch Update
22nd May 20077:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.